What RFK Jr.'s New Power Means for Vaccines, Weight-Loss Shots and Drug Ads

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Robert F. Kennedy Jr., center, departs his confirmation hearing on Jan. 29.Photographer: Tierney L. Cross/Bloomberg
Lock
This article is for subscribers only.

Robert F. Kennedy — a vaccine critic, obesity-drug skeptic and processed-foods hater — has secured his spot as head of the US Department of Health and Human Services after promising to “Make America Healthy Again.” The food and drug industries are girding for what’s next.

Drug company executives have largely followed the same playbook as other corporate titans to curry favor with President Donald Trump, making trips to his Mar-a-Lago club and donating to his second inaugural fund. Some, like Pfizer Inc. Chief Executive Officer Albert Bourla, were in Washington for the inauguration weekend. And within the corporate ranks, there was optimism that the new administration would bring with it less regulation.